RESPIRATORY SYNCYTIAL VIRUS INFECTION
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for vulnerable patients: remdesivir trial targets RSV in Immune-Weakened individuals
Disease control Recruiting nowThis study tests if the antiviral drug remdesivir can safely treat RSV (a common respiratory virus) in 60 adults whose immune systems are weakened by certain cancer or autoimmune treatments. Participants must have a confirmed RSV infection with symptoms. The main goal is to see i…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New RSV drug for babies shows promise in major trial
Symptom relief Recruiting nowThis study tests an oral medicine called deurremidevir in infants and young children (1 month to 3 years old) with RSV infection. About 498 children will receive either the drug or a placebo for 5 days. The goal is to see if the drug helps relieve symptoms like wheezing and rapid…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Phase: PHASE3 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated May 26, 2026 04:47 UTC
-
RSV study targets elderly hospitalizations in vietnam
Knowledge-focused Recruiting nowThis study looks at 1,000 adults aged 60 and older who are hospitalized in Vietnam with breathing problems or worsening heart/lung conditions. Researchers want to find out how many of these cases are caused by RSV (a common virus) and which types of RSV are involved. The goal is …
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS INFECTION
Sponsor: Tam Anh Research Institute • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC